Trial intelligence / Profile preview

Effect of low-dose theophylline on histone deacetylase activity and glucocorticoid function in COPD

2005-003344-62Phase 4Completed

Sponsor
Imperial College London
Start
Oct 2005
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Phase 4 trial of theophylline and fluticasone in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by Imperial College London. Primary endpoint: Sputum inflammatory cell counts. Started Oct 2005; status: completed.

02

Drugs

theophyllinefluticasone
03

Conditions

chronic obstructive pulmonary disease (COPD)

Beyond the preview

Go deeper on 2005-003344-62.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-003344-62.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call